Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.61 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.61 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.61 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | MTOR | P42345 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.55 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.55 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CDA | P32320 | 1/20 | 0.52 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.50 |
| ▸ | PYGM | P11217 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18512961 | 1.00 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL8402713 | 1.00 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL14946347 | 1.00 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL18574266 | 1.00 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL8402712 | 1.00 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL158123 | 1.00 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL14929312 | 1.00 | SLC28A1 (0.61) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL8772819 | 0.94 | SLC28A1 (0.55) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL18464358 | 0.89 | SLC28A1 (0.49) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA | |
| SCHEMBL19590395 | 0.88 | SLC28A1 (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5925 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747386-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE AGENTS AND USES THEREOF | Bisirna Therapeutics Pte. Ltd. (SG) | 2026-05-27 | — | — | EP | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260109727-A1 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2026-04-23 | — | — | US | claimed |
| US-12595282-B1 | Method for synthesizing nucleotide strands | HONGENE BIOTECH PTE. LTD. (SG) | 2026-04-07 | — | — | US | claimed |
| US-12503720-B2 | Multiplexed profiling of RNA and DNA modifications | Alida Biosciences Inc. (US) | 2025-12-23 | — | — | US | claimed |
| US-12480117-B2 | Compositions comprising modified circular polyribonucleotides and uses thereof | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-20250345406-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250325494-A1 | COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4632075-A2 | METHOD FOR REDUCING IMMUNOGENICITY OF RNA | BioNTech SE (DE) | 2025-10-15 | — | — | EP | claimed |
| WO-2002018404-A2 | NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C | F. HOFFMANN-LA ROCHE AG (CH) | 2002-03-07 | — | — | WO | claimed |
| JP-2001519538-A | — | — | 2001-10-23 | — | — | JP | claimed |
| WO-2001030989-A2 | METHOD FOR CREATING DIVERGENT POPULATIONS OF NUCLEIC ACID MOLECULES AND PROTEINS | CYTOS BIOTECHNOLOGY AG (US) | 2001-05-03 | — | — | WO | claimed |
| EP-1028970-A1 | REPLICA AMPLIFICATION OF NUCLEIC ACID ARRAYS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-08-23 | — | — | EP | claimed |
| US-6063628-A | Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA | UNIVERSITY OF WASHINGTON (US) | 2000-05-16 | — | — | US | claimed |
| EP-0948256-A1 | INDUCTION OF VIRAL MUTATION BY INCORPORATION OF MISCODING RIBONUCLEOSIDE ANALOGS INTO VIRAL RNA | THE UNIVERSITY OF WASHINGTON (US) | 1999-10-13 | — | — | EP | claimed |
| WO-1999019341-A1 | REPLICA AMPLIFICATION OF NUCLEIC ACID ARRAYS | PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) | 1999-04-22 | — | — | WO | claimed |
| WO-1998018324-A1 | INDUCTION OF VIRAL MUTATION BY INCORPORATION OF MISCODING RIBONUCLEOSIDE ANALOGS INTO VIRAL RNA | THE UNIVERSITY OF WASHINGTON (US) | 1998-05-07 | — | — | WO | claimed |
| EP-0770144-A1 | NUCLEIC ACID AMPLIFICATION METHOD USING A MODIFIED NUCLEOSIDE, AND DETECTION OF THE AMPLIFICATION PRODUCT USING ANTIBODIES | PARTEUROP DEVELOPPEMENT (FR) | 1997-05-02 | — | — | EP | claimed |
| WO-1996003526-A1 | NUCLEIC ACID AMPLIFICATION METHOD USING A MODIFIED NUCLEOSIDE, AND DETECTION OF THE AMPLIFICATION PRODUCT USING ANTIBODIES | PARTEUROP DEVELOPPEMENT (FR) | 1996-02-08 | — | — | WO | claimed |